The Federal Trade Commission is preparing to clamp down on the advertising claims made by manufacturers of homeopathic drugs, an action that could cause a major shakeup in a multibillion-dollar industry....
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: